Table: Kissei Pharm -2022/23 group results

Kissei Pharmaceutical

08/05/2023 07:00

May 8 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           67.49           65.38          74.50         35.50    
               (+3.2 pct)      (-5.3 pct)     (+10.4 pct)   (+8.0 pct)  
  Operating     loss 1.13       loss 1.40         4.20        900 mln   
  Recurring      598 mln         562 mln          5.20          1.50    
               (+6.4 pct)      (-83.8 pct)   (+768.4 pct)  (+385.5 pct) 
  Net
  Net             10.53           12.92          10.60          4.80    
               (-18.5 pct)    (+144.5 pct)    (+0.7 pct)    (+44.3 pct) 
  EPS          228.31 yen      280.20 yen     229.86 yen    104.09 yen  
  Ann Div       80.00 yen       56.00 yen      82.00 yen                
  -Q2 Div       40.00 yen       28.00 yen      41.00 yen                
  -Q4 Div       40.00 yen       28.00 yen      41.00 yen                
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T